D
$ Value
—
Shares
7,500
Price
—
Filed
Jan 28
Insider
Name
Civik Thomas
Title
—
CIK
0001723092
Roles
Director
Transaction Details
Transaction Date
2026-01-28
Code
D
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
Pursuant to that certain Arrangement Agreement, dated November 14, 2025 (the "Arrangement Agreement"), by and between the Issuer and XenoTherapeutics, Inc. (the "Parent"), Xeno Acquisition Corp. (the "Purchaser"), and XOMA Royalty Corporation ("XRC"), in exchange for (i) $2.20 in cash per share, plus (ii) one non-transferable contingent value right ("CVR") per share. | Pursuant to the Arrangement Agreement, the Purchaser acquired all of the issued and outstanding common shares of the Issuer for (i) $2.20 in cash per share plus (ii) one CVR per share.
Filing Info
Other Insiders at RPTX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| BVF PARTNERS L P/IL | — | — | 2026-01-28 |
| RHOADS ANN D | — | — | 2026-01-28 |
| SCHAFER CAROL | — | — | 2026-01-28 |
|
Forte Steve
EVP, CHIEF FINANCIAL OFFICER
|
— | — | 2026-01-28 |
|
Alves Sandra Isabelle Barros
SVP, Finance and CAO
|
— | — | 2026-01-28 |